At Memorial Sloan Kettering, our physicians and researchers continue to investigate innovative techniques, new drugs, and advanced treatments for bladder cancer. You may be eligible for one of many clinical trials under way that are testing new approaches in chemotherapy, surgery, or radiation therapy.
The trials can also help doctors compare the effectiveness of prevention strategies or other aspects of your care. Our Bladder Cancer Research Registry of Genetic and Clinical Information (also known as Genotype-Phenotype Urothelial Cancer Study), for example, is a database of genetic and clinical information that is helping doctors learn about risk factors for the disease as well as genetic markers that may predict a person’s response to treatment.
If you are eligible to participate in a clinical trial for bladder cancer, you may have access to new therapies that are not yet widely available. Our bladder cancer treatment team is experienced in selecting people with bladder cancer who are most likely to benefit from a particular therapy and can help guide you through the process of enrolling in the most appropriate clinical trial.
Here you can find a continually updated listing of Memorial Sloan Kettering’s current clinical trials for bladder cancer. To learn more about a study, choose from the list below.